Patent details

LUC00329 Product Name: Vaccin tétravalent contre la dengue (vivant, atténué) comprenant a) un virus de la dengue de sérotype 1 (vivant, atténué), dans lequel les gènes des protéines de surface spécifiques du sérotype sont incorporés dans le génome du virus de la dengue de type 2, b) un virus de la dengue de sérotype 2 (vivant, atténué), c) un virus de la dengue de sérotype 3 (vivant, atténué), dans lequel les gènes des protéines de surface spécifiques du sérotype sont incorporés dans le génome de la dengue de type 2, et d) un virus de la dengue de sérotype 4 (vivant, atténué), dans lequel les gènes des protéines de surface spécifiques du sérotype sont incorporés dans le génome de la dengue de type 2

Basic Information

Publication number:
LUC00329
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP221822695
Legal Status:
Pending & Published
Application number:
LUC00329
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/22/1699
Marketing Authorization Type:
Marketing Authorization Date:
06/12/2022
Marketing Authorization Status:
Claimed
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
27/02/2024
First Marketing Authorization date:
06/12/2022
Grant date:
Activation date:
Publication date:
28/02/2024
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
06/12/2037
SPC Extension Expiration:
06/12/2037
Rejection date:
Withdrawal date:

Owner

From:
27/02/2024
 
 

Name:
Takeda Vaccines, Inc.
Address:
75 Sidney Street, Cambridge, MA 02139, United States (US)

Name:
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services
Address:
4770 Buford Highway Technology Transfer Office (K79), Atlanta, GA 30341, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/02/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

Bulletin Heading:
SPC1
Bulletin edition number:
2024/04
Publication date:
11/03/2024
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication
Filing date Document type Number of pages
27/02/2024 MA publication 12
27/02/2024 Application Form 3
27/02/2024 Marketing authorization 3
27/02/2024 Summary of the product caracteristics 52
28/02/2024 Publication 1
28/02/2024 Outgoing Correspondence 2